Is Biomea Fusion, Inc. (BMEA) a Buy, Sell, or Hold?
NASDAQ : BMEA
Biomea Fusion, Inc.
$1.28 USD
$0.02 (1.59%)
- Volume
- 523.69K
- Average Volume
- 1.24M
- Market Capitalization
- $76.16M
- P/E Ratio
- -1.44
- Dividend Yield
- 0.00%
- Price Target
- $19.00
- Year High
- $2.99
- Year Low
- $0.87
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.98
Insider Activity Summary (Last 12 Months)
Insiders Buying
17
Insiders Selling
0
Amount of Insider Selling
-$
BMEA Insider Buying/Selling by Quarter
BMEA Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Faust Elizabeth | director | 2026-06-10 | A-Award | 1.15 | 2026-06-12 |
| AGUIAR ERIC | director | 2026-06-10 | A-Award | 1.15 | 2026-06-12 |
| Ray Sumita | director | 2026-06-10 | A-Award | 1.15 | 2026-06-12 |
| Averill Julianne | director | 2026-06-10 | A-Award | 1.15 | 2026-06-12 |
| Erdtmann Rainer M | director, officer: See Remarks | 2026-04-01 | A-Award | 1.49 | 2026-04-03 |
| Hitchcock Michael J.M. | director, officer: Interim CEO | 2026-04-01 | A-Award | 1.49 | 2026-04-03 |
| Erdtmann Rainer M | director, officer: See Remarks | 2025-12-31 | 0 | 2026-02-06 | |
| Erdtmann Rainer M | director, officer: See Remarks | 2025-12-31 | 0 | 2026-02-06 | |
| Erdtmann Rainer M | director, officer: See Remarks | 2025-12-11 | P-Purchase | 1.4333 | 2025-12-15 |
| Hitchcock Michael J.M. | director, officer: Interim CEO | 2025-12-02 | P-Purchase | 0.9918 | 2025-12-04 |
| Erdtmann Rainer M | director, officer: See Remarks | 2025-12-01 | P-Purchase | 1.05 | 2025-12-02 |
| Erdtmann Rainer M | director, officer: See Remarks | 2025-11-28 | P-Purchase | 1.1013 | 2025-12-02 |
| Hitchcock Michael J.M. | director, officer: Interim CEO | 2025-08-11 | A-Award | 1.53 | 2025-08-13 |
| Erdtmann Rainer M | director, officer: See Remarks | 2025-08-11 | A-Award | 1.53 | 2025-08-13 |
| Erdtmann Rainer M | director, officer: See Remarks | 2025-01-28 | G-Gift | 0 | 2025-08-13 |
| Erdtmann Rainer M | director, officer: See Remarks | 2025-01-31 | G-Gift | 0 | 2025-08-13 |
| Erdtmann Rainer M | director, officer: See Remarks | 2025-01-31 | G-Gift | 0 | 2025-08-13 |
| Erdtmann Rainer M | director, officer: See Remarks | 2025-01-31 | G-Gift | 0 | 2025-08-13 |
| Erdtmann Rainer M | director, officer: See Remarks | 2025-01-31 | G-Gift | 0 | 2025-08-13 |
| Erdtmann Rainer M | director, officer: See Remarks | 2025-01-31 | G-Gift | 0 | 2025-08-13 |
| Chen Bihua | 2025-08-01 | 0 | 2025-08-01 | ||
| Averill Julianne | director | 2025-07-22 | A-Award | 1.82 | 2025-07-24 |
| Averill Julianne | 2025-07-22 | 0 | 2025-07-24 | ||
| Faust Elizabeth | director | 2025-06-11 | A-Award | 2.5 | 2025-06-13 |
| AGUIAR ERIC | director | 2025-06-11 | A-Award | 2.5 | 2025-06-13 |
| Ray Sumita | director | 2025-06-11 | A-Award | 2.5 | 2025-06-13 |
| Chen Bihua | director, 10 percent owner: | 2025-06-11 | A-Award | 2.5 | 2025-06-13 |
| Hitchcock Michael J.M. | director, officer: Interim CEO | 2025-03-26 | A-Award | 2.52 | 2025-03-28 |
| Valle Franco | officer: Chief Financial Officer | 2024-11-30 | A-Award | 6.154 | 2024-12-02 |
| Hitchcock Michael J.M. | director | 2024-09-30 | P-Purchase | 10.06 | 2024-10-01 |
| Chen Bihua | director, 10 percent owner: | 2024-06-12 | A-Award | 4.63 | 2024-06-13 |
| Ray Sumita | director | 2024-06-12 | A-Award | 4.63 | 2024-06-13 |
| Faust Elizabeth | director | 2024-06-12 | A-Award | 4.63 | 2024-06-13 |
| Hitchcock Michael J.M. | director | 2024-06-12 | A-Award | 4.63 | 2024-06-13 |
| AGUIAR ERIC | director | 2024-06-12 | A-Award | 4.63 | 2024-06-13 |
| Valle Franco | officer: Chief Financial Officer | 2024-06-11 | P-Purchase | 4.4257 | 2024-06-12 |
| Valle Franco | officer: Chief Financial Officer | 2024-05-31 | A-Award | 3.7825 | 2024-06-12 |
| Frias Juan Pablo | officer: Chief Medical Officer | 2024-05-31 | A-Award | 8.942 | 2024-06-12 |
| Butler Thomas Andrew | director, 10 percent owner, officer: Chief Executive Officer | 2024-01-17 | A-Award | 14.44 | 2024-01-18 |
| Erdtmann Rainer M | director, officer: President and COO | 2024-01-17 | A-Award | 14.44 | 2024-01-18 |
| Valle Franco | officer: Chief Financial Officer | 2024-01-17 | A-Award | 14.44 | 2024-01-18 |
| Frias Juan Pablo | officer: Chief Medical Officer | 2024-01-17 | A-Award | 14.44 | 2024-01-18 |
| Erdtmann Rainer M | director, officer: President and COO | 2023-12-29 | G-Gift | 0 | 2024-01-03 |
| Erdtmann Rainer M | director, officer: President and COO | 2023-12-29 | G-Gift | 0 | 2024-01-03 |
| Erdtmann Rainer M | director, officer: President and COO | 2023-12-29 | G-Gift | 0 | 2024-01-03 |
| Erdtmann Rainer M | director, officer: President and COO | 2023-12-29 | G-Gift | 0 | 2024-01-03 |
| Erdtmann Rainer M | director, officer: President and COO | 2023-12-29 | G-Gift | 0 | 2024-01-03 |
| Erdtmann Rainer M | director, officer: President and COO | 2023-12-29 | G-Gift | 0 | 2024-01-03 |
| Valle Franco | officer: Chief Financial Officer | 2023-11-30 | A-Award | 3.7825 | 2023-12-01 |
| Frias Juan Pablo | officer: Chief Medical Officer | 2023-08-31 | A-Award | 16.87 | 2023-09-01 |
| Frias Juan Pablo | 2023-08-31 | 0 | 2023-09-01 | ||
| Hitchcock Michael J.M. | director | 2023-06-14 | A-Award | 38.9 | 2023-06-16 |
| Chen Bihua | director, 10 percent owner: | 2023-06-14 | A-Award | 38.9 | 2023-06-16 |
| Faust Elizabeth | director | 2023-06-14 | A-Award | 38.9 | 2023-06-16 |
| Ray Sumita | director | 2023-06-14 | A-Award | 38.9 | 2023-06-16 |
| AGUIAR ERIC | director | 2023-06-14 | A-Award | 38.9 | 2023-06-16 |
| Valle Franco | officer: Chief Financial Officer | 2023-05-31 | A-Award | 3.7825 | 2023-06-02 |
| A2A Pharmaceuticals, Inc. | 10 percent owner | 2023-05-31 | S-Sale | 33.81 | 2023-06-02 |
| A2A Pharmaceuticals, Inc. | 10 percent owner | 2023-06-01 | S-Sale | 34.5633 | 2023-06-02 |
| A2A Pharmaceuticals, Inc. | 10 percent owner | 2023-05-12 | S-Sale | 33.84 | 2023-05-17 |
| A2A Pharmaceuticals, Inc. | 10 percent owner | 2023-05-08 | S-Sale | 33.9931 | 2023-05-10 |
| A2A Pharmaceuticals, Inc. | 10 percent owner | 2023-05-09 | S-Sale | 34.5048 | 2023-05-10 |
| A2A Pharmaceuticals, Inc. | 10 percent owner | 2023-04-20 | S-Sale | 29.1188 | 2023-04-26 |
| A2A Pharmaceuticals, Inc. | 10 percent owner | 2023-03-31 | S-Sale | 31.25 | 2023-04-06 |
| A2A Pharmaceuticals, Inc. | 10 percent owner | 2023-03-31 | S-Sale | 31.25 | 2023-04-06 |
| Chen Bihua | director, 10 percent owner: | 2023-03-30 | P-Purchase | 30 | 2023-04-03 |
| Erdtmann Rainer M | director, officer: President & COO | 2022-12-31 | 0 | 2023-02-10 | |
| Erdtmann Rainer M | director, officer: President & COO | 2022-12-31 | 0 | 2023-02-10 | |
| Erdtmann Rainer M | director, officer: President & COO | 2022-12-31 | 0 | 2023-02-10 | |
| Erdtmann Rainer M | director, officer: President & COO | 2022-12-31 | 0 | 2023-02-10 | |
| Erdtmann Rainer M | director, 10 percent owner, officer: President and COO | 2021-04-15 | P-Purchase | 17 | 2023-02-10 |
| Erdtmann Rainer M | director, 10 percent owner, officer: President and COO | 2021-04-15 | P-Purchase | 17 | 2023-02-10 |
| Erdtmann Rainer M | officer: President and COO | 2023-01-06 | A-Award | 0 | 2023-01-10 |
| Valle Franco | officer: Chief Financial Officer | 2023-01-06 | A-Award | 0 | 2023-01-10 |
| Butler Thomas Andrew | officer: Chief Executive Officer | 2023-01-06 | A-Award | 0 | 2023-01-10 |
| Valle Franco | officer: Chief Financial Officer | 2022-11-30 | A-Award | 3.7825 | 2022-12-02 |
| Hitchcock Michael J.M. | director | 2022-11-14 | P-Purchase | 7.93 | 2022-11-16 |
| Valle Franco | officer: Chief Financial Officer | 2022-11-11 | P-Purchase | 7.6307 | 2022-11-14 |
| A2A Pharmaceuticals, Inc. | director: | 2022-08-16 | P-Purchase | 13.872 | 2022-08-19 |
| A2A Pharmaceuticals, Inc. | director: | 2022-07-21 | S-Sale | 11.21 | 2022-07-25 |
| A2A Pharmaceuticals, Inc. | director: | 2022-06-24 | S-Sale | 11.76 | 2022-06-28 |
| Ray Sumita | director | 2022-06-22 | A-Award | 10.2 | 2022-06-24 |
| Ray Sumita | director: | 2022-06-22 | A-Award | 0 | 2022-06-24 |
| Hitchcock Michael J.M. | director: | 2022-06-22 | A-Award | 0 | 2022-06-24 |
| AGUIAR ERIC | director | 2022-06-22 | A-Award | 10.2 | 2022-06-24 |
| AGUIAR ERIC | director: | 2022-06-22 | A-Award | 0 | 2022-06-24 |
| Faust Elizabeth | director: | 2022-06-22 | A-Award | 0 | 2022-06-24 |
| Faust Elizabeth | director: | 2022-06-22 | 0 | 2022-06-24 | |
| Chen Bihua | director, 10 percent owner: | 2022-06-22 | A-Award | 10.2 | 2022-06-24 |
| Cormorant Asset Management, LP | director: | 2022-06-22 | A-Award | 0 | 2022-06-24 |
| Biomea Health, LLC | director: | 2022-06-01 | J-Other | 0 | 2022-06-03 |
| Valle Franco | officer: Chief Financial Officer | 2022-05-31 | A-Award | 4.6665 | 2022-06-01 |
| Ray Sumita | director | 2022-03-03 | A-Award | 5.9 | 2022-03-07 |
| Ray Sumita | director: | 2022-03-03 | A-Award | 0 | 2022-03-07 |
| Valle Franco | officer: Chief Financial Officer | 2022-01-14 | P-Purchase | 8.6767 | 2022-01-18 |
| Butler Thomas Andrew | director, 10 percent owner, officer: CEO | 2021-12-04 | A-Award | 9.8 | 2021-12-07 |
| Erdtmann Rainer M | director, 10 percent owner, officer: President & COO | 2021-12-04 | A-Award | 9.8 | 2021-12-07 |
| Valle Franco | officer: Chief Financial Officer | 2021-12-04 | A-Award | 9.8 | 2021-12-07 |
| A2A Pharmaceuticals, Inc. | 10 percent owner | 2021-09-17 | P-Purchase | 10.96 | 2021-09-21 |
| Stergiopoulos Sotirios | director | 2021-09-17 | P-Purchase | 10.96 | 2021-09-21 |